Optiver Holding
SUPN icon

Optiver Holding’s Supernus Pharmaceuticals SUPN Stock Holding History

Optiver Holding’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Buy
+435
New +$20.9K ﹤0.01% 1517
2025
Q4 		– Sell
-248
Closed -$11.9K – 2978
2025
Q3 		$11.9K Buy
+248
New +$9.99K ﹤0.01% 1192

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Optiver Holding's SUPN Position: Q2 2026 in Review

Optiver Holding opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 435 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings. This is a return to the name: Optiver Holding previously reported a position in SUPN as recently as Q3 2025.

Optiver Holding first reported a position in SUPN in Q3 2025 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Optiver Holding held 435 shares of Supernus Pharmaceuticals worth $20.2K as of Q2 2026.
  • Supernus Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1517 holding.
  • Optiver Holding first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.